
About Vidit Pharma Sciences Private Limited
Data last updated:
Vidit Pharma Sciences Private Limited is a private limited company based in Mumbai, Maharashtra, India, a subsidiary of Enem Nostrum Remedies Private Limited. It operates in the biotechnology segment of the life sciences sector. It was incorporated on 21 January 2022.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U73200MH2022PTC375308.
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Anilkumar Shridhar Mulye and Shraddha Vinayak Dhamankar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Unit No 101 Gayatri Commercial Complex Behind Mittal Ind Estate Marol Andheri, Mumbai, Maharashtra, India – 400059.
For more details, the company can be reached via its website viditpharma.com.
Company details
Contact details
Vidit Pharma Sciences Private Limited's registered office is in Mumbai, Maharashtra. Its website is viditpharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressUnit No 101 Gayatri Commercial Complex Behind Mittal Ind Estate Marol Andheri, Mumbai, Maharashtra, India – 400059
- IndustryLife Sciences, Biotechnology
To see the full contact details of Vidit Pharma Sciences Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Vidit Pharma Sciences Private Limited
FY 2025 filings availableFinancial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ||
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | ||
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | ||
| Net Profit Margin | ||
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Vidit Pharma Sciences Private Limited, buy the company report.
Board of directors of Vidit Pharma Sciences Private Limited
Vidit Pharma Sciences has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anilkumar Shridhar Mulye Also directs: Enem Nostrum Remedies Private Limited, Nexgen Healthcare Private Limited, Symmetrix Biotech Private Limited and 5 more | Director | 11 Sep 2024 | 2 Years 2 Months | Current |
| Shraddha Vinayak Dhamankar Also directs: Thurs Organics Private Limited, Enem Nostrum Remedies Private Limited, Nexgen Healthcare Private Limited and 5 more | Director | 21 Jan 2022 | 4 Years 9 Months | Current |
Auditor
Vidit Pharma Sciences Private Limited is audited by GOKHALE & SATHE for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| GOKHALE & SATHE | FY 2023 | 103264W |
Shareholding
The shareholding of Vidit Pharma Sciences Private Limited is on record for FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Vidit Pharma Sciences Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Vidit Pharma Sciences Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Vidit Pharma Sciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Vidit Pharma Sciences Private Limited has 1 active EPFO establishment as of Nov 11, 2026.
GST
No GST registration is on our record for Vidit Pharma Sciences Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Vidit Pharma Sciences Private Limited has 4 board changes on record since 2022: 2 appointments and 2 cessations. The latest: Anilkumar Shridhar Mulye ceased to be Additional Director on 29 Sep 2024.
Frequently asked questions
Vidit Pharma Sciences is an active private limited company based in Mumbai, Maharashtra, India. The company works in biotechnology, within the life sciences industry. It was incorporated on 21 January 2022 (4+ years old) and is registered under CIN U73200MH2022PTC375308.
Vidit Pharma Sciences has 2 current directors:
- Anilkumar Shridhar Mulye - Director
- Shraddha Vinayak Dhamankar - Director
The latest financial statements of Vidit Pharma Sciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The CIN (Corporate Identification Number) of Vidit Pharma Sciences is U73200MH2022PTC375308. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Vidit Pharma Sciences was incorporated on 21 January 2022, making it 4+ years old. It is registered with the Registrar of Companies, Mumbai.
Anilkumar Shridhar Mulye ceased to be Additional Director on 29 Sep 2024. Jayant Hari Ranade ceased to be Director on 15 Sep 2024. Anilkumar Shridhar Mulye was appointed as Director on 11 Sep 2024. Vidit Pharma Sciences has 4 board changes on record in total.
Vidit Pharma Sciences can be reached through the website viditpharma.com. Its registered office is in Mumbai, Maharashtra, India.
The registered office of Vidit Pharma Sciences is at Unit No 101 Gayatri Commercial Complex Behind Mittal Ind Estate Marol Andheri, Mumbai, Maharashtra, India – 400059.
Vidit Pharma Sciences operates in the life sciences industry, in the biotechnology segment.
Vidit Pharma Sciences is registered under the jurisdiction of the Registrar of Companies (ROC), Mumbai.

